Record mula sa primary source
Decision-gradeTopline na resulta
Nag-ulat ang Veradermics ng positibong Phase 2/3 topline data para sa VDPHL01 sa male pattern hair loss
Natugunan ng Phase 2/3 Study 302 ang lahat ng primary at key secondary endpoints na may statistical significance. Ang VDPHL01 ay nagdulot ng mabilis at dose-dependent na pagtaas sa non-vellus hair count at patient-reported hair coverage kumpara sa placebo sa Month 6, na may generally well-tolerated safety profile at walang treatment-related SAEs o cardiac AESIs.
Mahahalagang fact
- Na-file
- Abr 27, 2026, 01:10 PM
- Kaganapan
- Topline na resulta
- Direksyon
- Positibo
- Kumpanya
MANEVeradermics- Asset
- VDPHL01
- Pinagmulan
- SEC 8-K
- Kumpiyansa
- May source
- Bilang ng pasyente
- 519
- IGA bumuti sa QD
- 72.0%
- IGA bumuti sa BID
- 84.4%
- AAIRS bumuti sa QD
- 79.3%
- AAIRS bumuti sa BID
- 86.0%
- Non-vellus TAHC sa QD
- 30.3 buhok/cm²
- Non-vellus TAHC sa BID
- 33.0 buhok/cm²
- p value lahat ng endpoints
- <0.0001
- AAIRS bumuti sa placebo
- 35.6%
- AAIRS lubos na bumuti sa QD
- 48.4%
- AAIRS lubos na bumuti sa BID
- 62.9%
- Non-vellus TAHC sa placebo
- 7.3 buhok/cm²
Sipi mula sa source
mane-20260427 0001827635 False 0001827635 2026-04-27 2026-04-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2026 VERADERMICS, INCORPORATED (Exact name of registrant as specified in its charter) Delaware 001-43097 84-3304423 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 470 James Street New Haven , CT 06513 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number, including area code): ( 228 ) 372-3376 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Fo
Higit pa tungkol sa asset na ito
Kapansin-pansin
May 27, 2026
11:30 AM
MANEVeradermicsVeradermics ipapakita ang VDPHL01 Phase 2/3 topline sa 2026 World Congress for Hair Research